JPWO2023205241A5 - - Google Patents

Info

Publication number
JPWO2023205241A5
JPWO2023205241A5 JP2024561629A JP2024561629A JPWO2023205241A5 JP WO2023205241 A5 JPWO2023205241 A5 JP WO2023205241A5 JP 2024561629 A JP2024561629 A JP 2024561629A JP 2024561629 A JP2024561629 A JP 2024561629A JP WO2023205241 A5 JPWO2023205241 A5 JP WO2023205241A5
Authority
JP
Japan
Prior art keywords
oral
tablets
compound
group
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024561629A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513297A (ja
JP2025513297A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/019107 external-priority patent/WO2023205241A1/en
Publication of JP2025513297A publication Critical patent/JP2025513297A/ja
Publication of JPWO2023205241A5 publication Critical patent/JPWO2023205241A5/ja
Publication of JP2025513297A5 publication Critical patent/JP2025513297A5/ja
Pending legal-status Critical Current

Links

JP2024561629A 2022-04-21 2023-04-19 ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス Pending JP2025513297A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263333391P 2022-04-21 2022-04-21
US63/333,391 2022-04-21
PCT/US2023/019107 WO2023205241A1 (en) 2022-04-21 2023-04-19 Gamma-hydroxybutyrate delivering compounds and processes for making and using them

Publications (3)

Publication Number Publication Date
JP2025513297A JP2025513297A (ja) 2025-04-24
JPWO2023205241A5 true JPWO2023205241A5 (https=) 2026-04-08
JP2025513297A5 JP2025513297A5 (https=) 2026-04-08

Family

ID=86332306

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2024561629A Pending JP2025513297A (ja) 2022-04-21 2023-04-19 ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス
JP2024561630A Pending JP2025513298A (ja) 2022-04-21 2023-04-19 ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス
JP2024561627A Pending JP2025513295A (ja) 2022-04-21 2023-04-19 ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス
JP2024561628A Pending JP2025513296A (ja) 2022-04-21 2023-04-19 ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2024561630A Pending JP2025513298A (ja) 2022-04-21 2023-04-19 ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス
JP2024561627A Pending JP2025513295A (ja) 2022-04-21 2023-04-19 ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス
JP2024561628A Pending JP2025513296A (ja) 2022-04-21 2023-04-19 ガンマ－ヒドロキシブチラート送達化合物ならびにその作製および使用のためのプロセス

Country Status (12)

Country Link
US (6) US20230338543A1 (https=)
EP (4) EP4511122A1 (https=)
JP (4) JP2025513297A (https=)
KR (4) KR20250005145A (https=)
CN (4) CN118974001A (https=)
AU (4) AU2023255392A1 (https=)
CA (4) CA3249689A1 (https=)
CL (4) CL2024003173A1 (https=)
IL (4) IL314432A (https=)
MA (4) MA66991A1 (https=)
MX (4) MX2024012884A (https=)
WO (4) WO2023205233A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119775157B (zh) * 2024-12-11 2025-09-19 西安味品荟食品科技有限公司 一种呈味化合物及其制备方法及应用
CN120699637B (zh) * 2025-06-10 2025-12-05 合肥中聚和成光电材料股份有限公司 液晶取向剂、液晶取向膜及液晶显示元件

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4973304U (https=) 1972-10-12 1974-06-25
DE3909485A1 (de) * 1989-03-22 1990-09-27 Basf Ag Verfahren zur herstellung von butandiol-1,4 und tetrahydrofuran
JP3609457B2 (ja) * 1994-08-25 2005-01-12 三井化学株式会社 サリチル酸誘導体、該誘導体の金属塩および感熱記録材料
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
JP4576737B2 (ja) 2000-06-09 2010-11-10 Ｊｓｒ株式会社 感放射線性樹脂組成物
JP4838437B2 (ja) * 2000-06-16 2011-12-14 Ｊｓｒ株式会社 感放射線性樹脂組成物
ES2383673T3 (es) * 2000-09-22 2012-06-25 Jpi Commercial, Llc Composiciones de gamma-hidroxibutirato que contienen portadores de hidrato de carbonos
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations
JP4973304B2 (ja) * 2007-04-27 2012-07-11 日油株式会社 １，２，３，４−シクロブタンテトラカルボン酸の製造方法
WO2011057199A1 (en) * 2009-11-06 2011-05-12 Adenios, Inc. Compositions for treating cns disorders
JP5531034B2 (ja) * 2012-01-31 2014-06-25 富士フイルム株式会社 感光性樹脂組成物、硬化膜の形成方法、硬化膜、有機ｅｌ表示装置及び液晶表示装置
US8591922B1 (en) * 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
ITMI20132041A1 (it) * 2013-12-06 2015-06-07 Ct Lab Farm Srl Derivati dell'acido gamma-idrossibutirrico, loro preparazione e loro uso medico.
CN113061089A (zh) * 2015-09-23 2021-07-02 凯瑞康宁生物工程（武汉）有限公司 γ-羟基丁酸的前药及其组合物和用途
US20200114015A1 (en) * 2017-04-11 2020-04-16 John K. Thottathil Novel Alpha-Hydroxy Carboxylic Acid And Derivatives And Other GRAS- Based Prodrugs Of Gamma-Hydroxybutyrate (GHB) And Uses Thereof
WO2022214025A1 (zh) * 2021-04-08 2022-10-13 厦门赛诺邦格生物科技股份有限公司 一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用

Similar Documents

Publication Publication Date Title
HRP20170555T1 (hr) Metilfenidatni prolijekovi, postupci za njihovo dobivanje i njihova primjena
US20120010159A1 (en) Combination therapies with cox-2 inhibitors and treprostinil
NO328959B1 (no) Stabiliserte farmasoytiske preparater av gamma-aminosmorsyrederivater og fremgangsmate for fremstilling av disse
RS55142B1 (sr) Deuterisani derivati kateholamina i medikamenti koji obuhvataju pomenuta jedinjenja
JP2021512876A5 (https=)
TWI534125B (zh) Novel compounds, salts thereof or solvates thereof, and pharmaceutical compositions and pharmaceutical products containing the same
JPH07206677A (ja) エンドペプチダーゼ２４．１５阻害剤
WO2019038637A1 (en) FORMS OF CRYSTALLINE SALT OF LEVODOPA AMIDE AND METHODS OF MAKING AND USING THEM
JPWO2023205241A5 (https=)
JPWO2023205237A5 (https=)
JP2020533402A5 (https=)
JPWO2023205245A5 (https=)
JPWO2023205233A5 (https=)
AU2003289841B2 (en) Deuterated catecholamine derivatives and medicaments comprising said compounds
AU2003303040B2 (en) Pregabalin derivatives for the treatment of fibromyalgia and other disorders
CA2884173C (en) Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
JP5985985B2 (ja) 胃腸への影響が減少した即効型ナプロキセン組成物
CA2640402C (en) Alpha-2-delta ligands for non-restorative sleep
US11844754B2 (en) Methods for treatment of Parkinson's disease
US20250082595A1 (en) Methods and compositions for treating parkinson’s disease
JP2014005275A (ja) 医薬用途
WO2024238820A3 (en) Bcat2 inhibitors
JPWO2022190100A5 (https=)
NZ565180A (en) Pregabalin derivatives for the treatment of fibromyalgia and other disorders